Skip to main content

AMERIPRISE FINANCIAL INC

Position in NVO — Novo Nordisk A S

CIK 820027 MINNEAPOLIS, MN

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$80,944,003
+$16,733,485 QoQ
Shares Held
1,688,444
-3.4% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#39
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

AMERIPRISE FINANCIAL INC holds $17,081,497,167 across 17 Drug Manufacturers - General names. NVO ranks #10 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $80,944,003 1,688,444
2026-03-31 $64,210,518 1,747,225
2025-12-31 $88,336,633 1,736,176
2025-09-30 $80,433,364 1,449,511
2025-06-30 $111,086,308 1,609,480
2025-03-31 $100,152,962 1,442,295
2024-12-31 $113,435,948 1,318,716
2024-09-30 $143,418,384 1,204,488
2024-06-30 $156,770,483 1,098,294
2024-03-31 $141,309,336 1,100,540
2023-12-31 $109,888,519 1,062,238
2023-09-30 $97,408,196 1,071,126
2023-06-30 $80,155,692 495,308
2023-03-31 $71,259,389 447,778
2022-12-31 $63,576,775 469,756
2022-09-30 $47,116,620 472,916
2022-06-30 $65,068,433 583,940
2022-03-31 $91,188,262 821,146
2021-12-31 $93,109,520 831,335
2021-09-30 $81,855,244 852,570
2021-06-30 $80,542,172 961,468
2021-03-31 $62,674,776 929,617
2020-12-31 $64,144,721 918,321
2020-09-30 $62,747,500 903,752
2020-06-30 $46,125,551 704,422
2020-03-31 $82,502,052 1,370,466